Long-term sustained-release therapy pays off in management of chronic, vision-threatening disease.
David Lally, MD
Advertisement
Articles by David Lally, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
AAO 2025: Subretinal drusenoid deposits in Black and Hispanic patients with AMD
2
EyePoint Pharmaceuticals details phase 3 program evaluating vorolanib intravitreal insert (DURAVYU) for DME
3
AAO 2025: Inder Paul Singh, MD, shares his experience with the Academy Technician Training Platform
4
